PSIVIDA LIMITED (PSD.AX)
From ValueWiki
Business Description from asx.com.au: Commercialisation of a unique and exciting bio-engineering platform technology known as BioSilicon which is based on exploiting the biofunctionality of the silicon semiconductor in a variety of healthcare applications.[1]
|
|
Company Analysis
You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.
The edit window has shortcut and help links if you need them.[2] Be bold!
News Feed
Leadership
- PSIVIDA LIMITED Executive Information
- PSIVIDA LIMITED Directors / Senior Management[1]
Dr David Mazzo (Chairman, Non Exec. Director) Dr Paul Ashton (Executive Director, Managing Director) Mr Michael Soja (CFO) Mr Brian Leedman (Investor Relations) Dr Roger Aston (Director) Mr Stephen Lake (Non Exec. Director) Mr Michael Rogers (Non Exec. Director)
Risks
This section needs content! Click the blue edit link (to the right) to contribute.
Research Links
- PSIVIDA LIMITED Profile
- PSIVIDA LIMITED Fundamentals
- PSIVIDA LIMITED Technical Analysis
- PSIVIDA LIMITED Contact Information[1]
- Website: http://www.psivida.com.au/
- Address: Level 12 , BGC Building , 28 The Esplanade , PERTH , WA, AUSTRALIA, 6000
- Phone: 08 9226 5099
- Fax: 08 9226 5499
- Share Registry: COMPUTERSHARE INVESTOR SERVICES PTY LIMITED LEVEL 2, RESERVE BANK BUILDING , 45 ST GEORGE'S TERRACE , PERTH , WA, AUSTRALIA, 6000
- Share Registry Phone: 1300 787 575 (BKR ONLY)
- PSIVIDA LIMITED Message Boards
Notes
- ↑ 1.0 1.1 1.2 http://www.asx.com.au/asx/research/CompanyInfoSearchResults.jsp?searchBy=asxCode&allinfo=on&asxCode=PSD ASX.com.au
- ↑ This is a sample reference.
